Lucintel Newsletter

Business News by Lucintel

Bookmark and Share

Wednesday, April 1, 2026

Lucintel Forecasts the Global Albumin (as Excipient) Market to Grow with a CAGR of 6.5% from 2025 to 2031

According to a market report by Lucintel, the future of the global albumin (as excipient) market looks promising with opportunities in the cell culture media and medical excipient markets. The global albumin (as excipient) market is expected to grow with a CAGR of 6.5% from 2025 to 2031. The major drivers for this market are the increasing demand for biologic drugs, the rising use in vaccine formulations, and the growing focus on drug delivery systems.

A more than 150-page report to understand trends, opportunity and forecast in global albumin (as excipient) market to 2031 by type (20-25% concentrations and 5% concentrations), application (cell culture media and medical excipient), and region (North America, Europe, Asia Pacific, and the Rest of the World).

Lucintel forecasts that, within the type category, 20-25% concentration is expected to witness higher growth over the forecast period.

Within the application category, cell culture media is expected to witness higher growth.

Download sample by clicking on albumin (as excipient) market.

In terms of region, APAC is expected to witness the highest growth over the forecast period.

CSL, Grifols, Takeda, Octapharma, Hualan Bio, CBPO, Shanghai RAAS, Kedrion, LFB Group, Tiantan Bio are the major suppliers in the albumin (as excipient) market.

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com. To get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.

About Lucintel

At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.

Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email:
roy.almaguer@lucintel.com
Tel. +1-972-636-5056

Explore Our Latest Publications

Exosome Diagnostic and Therapeutic Market

DNA/RNA Extraction Equipment Market

Digital Radio Frequency Memory Market

Die Bonder Equipment Market

Customized Genetic Testing Market

 

No comments:

Post a Comment